It is a synthetic quinolinium small molecule studied as an inhibitor of nicotinamide N-methyltransferase
Green R, Allen L, Bjrke-Monsen A, Brito A, Guant J, Miller J, Molloy A, Nexo E, Stabler S, Toh B, Ueland P, Yajnik C
If successful, this could lay the foundation for more targeted and effective treatments and delivery options, particularly for patients at high risk of severe periodontal diseases, such as the elderly, diabetics, and immunocompromised. The study included multiple students from different programs, including undergraduate students at the Penn Center for Undergraduate Research and Fellowships , dental students from Penn Dental Medicines summer research program, and a graduate student from Penn Dental Medicines DScD program
Frequency varies depending on the clinical reason and individual needs
Current evidence suggests BPC-157 is pleiotropic acting through multiple mechanisms simultaneously depending on the tissue type and injury context